Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer

Clinical trial NCT00112996 · COMPLETED

Trial details

NCT number: NCT00112996
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neurotoxicity Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2007-01-01
Primary completion: 2014-04-01
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.